HOWL - Werewolf Therapeutics Inc. Qarzning balans kapitallashuviga nisbati

werewolftx.com (HOWL) kompaniyasining korporativ logotipi

Werewolf Therapeutics (HOWL) o'smalarni maqsadli yo'q qilish uchun PREDATOR texnologiyasi yordamida innovatsion sitokinlarni ishlab chiqadi. Ushbu qarzning bozor kapitalizatsiyasiga nisbati grafigi moliyaviy barqarorlikni yaqqol namoyish etadi, bunda 0.00 qiymati metrika darajasini aks ettiradi. Savdolarning yo'qligi bilan tavsiflanadigan joriy R&D bosqichi tadqiqot xarajatlarini oshiradi. Biroq, ilmiy ustunlik uchun sog'liqni saqlash gigantlari bilan bo'lgan shiddatli raqobat startap ishlanmalarining qadrsizlanishi xavflarini yuzaga keltiradi.

HOWL Werewolf Therapeutics Inc.: Qarzning balans kapitallashuviga nisbati 04.07.2022 - 27.10.2026 oraligʻida
Werewolf Therapeutics Inc. tayyor mahsulotlari

Ushbu ko'rsatkich biznesning qarz mablag'lariga bog'liqligini uning aksiyalarining bozor qiymatiga nisbatan baholaydi. GURU.Markets platformasida umumiy qarzdorlikning bozor kapitalizatsiyasiga nisbatini tahlil qilish orqali investor aktivlarning kunlik qayta baholashlariga asoslangan kredit yuklamasi dinamikasini kuzatishi mumkin. Metrika umumiy majburiyatlarning kompaniyaning joriy bozor qiymatiga nisbati sifatida hisoblanadi. Werewolf Therapeutics (HOWL) uchun bu juda muhimdir, chunki PREDATOR platformasining agressiv rivojlantirilishini moliyalashtirish qarz va kapitalizatsiya o'rtasidagi muvozanatni talab qiladi. Ushbu sog'liqni saqlash gigantining yuqori ilmiy mahsuldorligi barqaror resurslar tuzilmasi bilan ta'minlanishi lozim.

Werewolf Therapeutics raqobatchilari

ImmunityBio, Inc. - Balans kapitallashuviga qarzlar|immunocore.com - Qarzning balans qiymatiga nisbati|JANX (Janux Therapeutics, Inc.) - Qarzning balans kapitallashuviga nisbati|RCUS: Balans qiymatiga qarzlar|Zymeworks Corp (ZYME) - Qarzning balans kapitallashuviga nisbati|TNGX (Tango Therapeutics Corp) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati IOVA (Iovance Biotherapeutics)|Balans qiymatiga qarzlar immatics.com|XNCR: Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Compass Therapeutics Inc CMPX|REPL: Qarzning balans qiymatiga nisbati|LYEL - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Innate Pharma S.A. (IPHA)|PYXS - Qarzning sof aktivlarga nisbati|cgen.com - Balans kapitallashuviga qarzlar|IOBT (IO Biotech Inc) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati STRO|Qarzning balans qiymatiga nisbati INKT|Qarzning balans kapitallashuviga nisbati IMMX (Immix Biopharma, Inc.)|Qarzning balans qiymatiga nisbati ALX Oncology Holdings Inc. ALXO|Qarzning balans qiymatiga nisbati CUE (Cue Biopharma, Inc.)|PDS Biotech - Balans kapitallashuviga qarzlar|Sonnet BioTherapeutics Holdings Inc. (SONN) - Qarzning balans kapitallashuviga nisbati|MAIA: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati LIMN|Balans qiymatiga qarzlar LAVA Therapeutics|NextCure - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Leap Tx (LPTX)|Qarzning balans qiymatiga nisbati Intensity Therapeutics|Qarzning balans kapitaliga nisbati senseibio.com (SNSE)|Balans kapitallashuviga qarzlar Theriva Biologics, Inc.|Qarzning sof aktivlarga nisbati Gritstone bio Inc. GRTS|KA (Kineta) - Balans kapitallashuviga qarzlar|NEXI: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati turnstonebio.com TSBX|Vaccinex Inc (VCNX) - Qarzning sof aktivlarga nisbati|HARP (Harpoon Therapeutics) - Balans kapitallashuviga qarzlar